Akso Begin Period Cash Flow from 2010 to 2024
| AHG Stock | USD 1.23 0.12 10.81% |
Begin Period Cash Flow | First Reported 2010-12-31 | Previous Quarter 9.2 M | Current Value 8.7 M | Quarterly Volatility 34.6 M |
Check Akso Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akso Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 187.4 K, Selling General Administrative of 13.5 M or Selling And Marketing Expenses of 160 K, as well as many indicators such as Price To Sales Ratio of 28.74, Dividend Yield of 0.088 or PTB Ratio of 0.35. Akso financial statements analysis is a perfect complement when working with Akso Health Valuation or Volatility modules.
Akso | Begin Period Cash Flow |
Latest Akso Health's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of Akso Health Group over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Akso Health's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Akso Health's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
Akso Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 19,245,261 | |
| Geometric Mean | 5,755,666 | |
| Coefficient Of Variation | 179.73 | |
| Mean Deviation | 20,557,885 | |
| Median | 8,733,068 | |
| Standard Deviation | 34,590,248 | |
| Sample Variance | 1196.5T | |
| Range | 131.7M | |
| R-Value | 0.25 | |
| Mean Square Error | 1210.5T | |
| R-Squared | 0.06 | |
| Significance | 0.38 | |
| Slope | 1,903,486 | |
| Total Sum of Squares | 16750.8T |
Akso Begin Period Cash Flow History
About Akso Health Financial Statements
Akso Health stakeholders use historical fundamental indicators, such as Akso Health's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Akso Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Akso Health's assets and liabilities are reflected in the revenues and expenses on Akso Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Akso Health Group. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 9.2 M | 8.7 M |
Currently Active Assets on Macroaxis
When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:Check out the analysis of Akso Health Correlation against competitors. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akso Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.21) | Revenue Per Share 0.051 | Quarterly Revenue Growth 0.148 | Return On Assets (0.07) | Return On Equity (0.12) |
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akso Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akso Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akso Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.